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ABSTRACT 
In May 1996, in the Region of the Americas, over 4 years had 
elapsed since the last confirmed case of paralytic poliomyelitis 
due to wild polio virus had been detected, on August 23, 1991, 
in a 2-year-old boy, in Peru. This fact is of historic significance 
in the annals of public health, and the successes experienced 
in the Americas served as the template for the launching of 
the global eradication of poliomyelitis by the World Health 
Assembly, in May 1988. During 1995, there were less than 
10,000 cases of polio reported worldwide, the lowest number 
of cases ever reported, and the target of global eradication by 
the year 2000 is well within grasp. The strategies being imple- 
mented worldwide for the achievement of polio eradication are 
based on those that succeeded in the Region of the Americas. 
Though endemic countries are contributing 80% of the funds 
for polio eradication, an additional US $500 million is needed 
over the next 5 years from external collaborating partners to 
eliminate this virus and to eradicate polio. 
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Traditionally, the countries of the Americas introduced 
vaccines as soon as they became available. However, 
before 1977, vaccine utilization did not follow a regular 
and continuous pattern within well-structured permanent 
programs. In September 1977, following a :May 1977 
World Health Assembly Resolution, the Directing Council 
of the Pan American Health Organization (PAIIO) estab- 
lished the Expanded Program on Immunizatio~n (EPI) in 
the Americas, with the following objectives: 
1. Reduction of morbidity and mortality due to six vac- 
cine-preventable diseases (diphtheria, tetanus, per- 
tussis, tuberculosis, poliomyelitis, and measles) by 
providing immunization services to all children of 
the world by 1990; 
2. Promotion of self-reliance in the delivery of immu- 
nization services through routine basic health ser- 
vices; and 
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3. Promotion of regional self-sufficiency for vaccine pro- 
duction and quality control. 
The strategies to increase the efficiency of the immu- 
nization services relied on several key p0ints.l They 
included simultaneous administration of several vaccines 
to reduce the number of visits required. Children were 
scheduled to receive three doses of poliomyelitis vac- 
cine, three of diphtheria-pertussis-tetanus toxoids (DPT) 
vaccine, one of measles vaccine, and one of bacille Cal- 
mette-Guerin (BCG). A total of only four visits would be 
needed to complete the vaccination schedule. Infants 
less than 1 year old and women of child-bearing age con- 
stitute the priority target groups. Vaccinations should be 
administered to them because they are at greatest risk 
of contracting these diseases and respond best to immu- 
nization. 
Immunizations must be integrated into the regular 
activities of maternal and child health services. Immu- 
nization should be an integral part of primary health care 
and should be maintained continuously over the years. 
Expansion of these activities should be carried out in 
stages, beginning first in existing health facilities, then 
encouraging outreach services from these facilities, and 
finally covering populations that cannot be reached from 
existing facilities. 
From 1977 to 1984, information systems were put 
into place to monitor immunization coverage in children 
under 1 year of age, which rose from around 20% to 
nearly 50% for most antigens, and for oral poliomyelitis 
vaccine, it rose to nearly SO%. 
PROGRAM STRATEGIES 
The strategies for polio eradication used in the Region of 
the Americas relied on the achievement and maintenance 
of high immunization levels in the population at risk (chil- 
dren under 5 years of age) and disease surveillance.2 
Achievement of High Levels of Immunity 
The basic issue that needed to be addressed at the launch- 
ing of the polio eradication initiative in the Americas was 
the determination of the optimal strategy for achieving 
and maintaining high vaccination coverage. The experi- 
ences in Brazil with National Immunization Days (NIDs) 
with live oral polio vaccine (OPV), showed a dramatic 
decline in the number of cases in a short period of time 
(Figure 1). 
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Figure 1. Polio cases by 4-week period, Brazil, 1975-l 984. Source: 
Ministry of Health, Brazil. 
These NIDs are generally held twice a year, 1 or 2 
months apart. During each NID, 20 million children 
under 5 years of age in Brazil are vaccinated with OPV3 
However, NIDs are not a new approach*; they have been 
used since the introduction of OPV in the early 1960~ in 
Cuba, where transmission is believed to have been inter- 
rupted in the early 1960s. Live oral polio vaccine has 
never been used routinely in the country, but is given 
only during NIDs, held in January and March of every 
year.5 Similar strategies have been used in industrialized 
countries, including the United States, England, and 
Japan, as well as the former Soviet Union and eastern 
European countries. The recent observation in Brazil, of 
the success of NIDs, is a reminder of the effectiveness of 
this strategy to interrupt transmission of the wild polio 
virus. It also demonstrates that it is logistically possible 
to implement this strategy in a large developing country, 
such as Brazil. 
This experience was critical to the development of 
the approaches to be used in the different countries in 
the Americas. The countries were categorized into two 
groups: those endemic for polio, or reporting at least one 
case in any of the last 3 years, and those free of endemic 
polio, or not reporting any cases during the last 3 years. 
The latter group was subdivided into two groups: those 
in which vaccine coverage was below or above 80% 
among children under 1 year of age. The group with less 
than 80% vaccine coverage, was considered to be at 
higher risk of acquisition of disease if wild polio virus 
were introduced. 
Those countries in group 2 had in common a well- 
developed health infrastructure and an efficient EPI. 
Those in group 1 had a less developed health infra- 
structure and deficiencies in their EPI. It was then rec- 
ommended that countries in group 1 complement their 
EPI with MDs, in which not only OPV but also the other 
EPI vaccines would be delivered. In this manner, the cov- 
erage for all EPI vaccines would benefit from the strategy 
to interrupt transmission of the wild polio virus. By 1987, 
all countries in that group were utilizing MDs as part of 
their basic immunization strategies. Health workers were 
interviewed in several countries and over two thirds felt 
that the best strategy to deliver vaccines was a mixture 
of routine services complemented by NIDs. This makes 
sense, because if an existing health infrastructure does 
not reach all the population in a given country, outreach 
programs are necessarily called for if immunization cov- 
erage is to be universal. National Immunization Days, in 
this context, play an important role in complementing 
the institutional delivery of vaccines. 
Mop-up Operations 
With the implementation of MDs, polio transmission was 
curtailed and remained at low levels in few areas or dis- 
tricts in some few countries. At this stage, circa 1988, 
program managers determined the areas at risk for con- 
tinuing transmission, which were those that had reported 
at least one case of polio within any of the previous 3 
years, had low immunization coverage or were areas of 
heavy migration. About 1000 districts of the nearly 14,000 
districts existing in Latin America and the Caribbean were 
targeted for mop-up operations. These operations con- 
sisted of two rounds of house-to-house vaccination of all 
children under 5 years of age, 1 to 2 months apart, regard- 
less of previous vaccination status. 
These operations were critical to enhance immunity 
in those areas, and transmission was finally interrupted 
with only two outbreaks detected in 1991; one in Colom- 
bia, with eight cases (last onset in April 1991) and the 
one in Peru, with last onset in August 1991 (Figure 2).6 
Surveillance 
To facilitate surveillance, uniform case definitions for 
poliomyelitis were adopted: a suspect case being any 
case of acute paralytic illness in a child less than 15 years 
of age or in any individual in which the attending physi- 
cian strongly suspected poliomyelitis. All cases were to 
be seen within 48 hours by a trained epidemiologist for 
a thorough investigation. If the case was acute flaccid 
paralysis (AFP), it would be classified as probable 
poliomyelitis, and two stool specimens, collected 24 
hours apart, would be collected and sent to one of the 
laboratories included in a network of diagnostic labora- 
tories that had been established. After 10 weeks, the case 
would be finally classified, as confirmed poliomyelitis, if 
wild polio virus had been isolated from the stools, or if 
the patient had died within 60 days of onset or had been 
lost to follow-up. In the later stages of the program 
another category, compatible poliomyelitis, was added 
to the patient classification. Compatible poliomyelitis 
cases meet other criteria for diagnosis, but there has not 
been proper collection of two stools within 2 weeks of 
onset of paralysis. Such cases, basically represented fail- 
ures of the surveillance system and could not be defi- 
nitely omitted as paralytic disease due to other cause. 
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Figure 2. Outbreaks of polio in the Americas, 1991. Last dates of 
onset: Colombia, May 24, 1991; Peru, August 23, 1991. Source: 
EPUPAHO. 
The existing system of disease reporting was orga- 
nized and strengthened as a reporting network of AFP 
cases, initially including all health facilities that were most 
likely to see cases of AFP: neuropediatric clinics, hospi- 
tals, and rehabilitation centers. They were asked1 to report 
weekly even in the absence of cases of AFP (negative 
reporting). As the program evolved, it was observed that 
many patients were coming to these institutio:ns several 
days or weeks after onset of paralysis, too late ifor appro- 
priate collection of stool specimens. The reporting net- 
work was then extended to include health facilities in 
every district of the countries, expanding to’ approxi- 
mately 22,000 health institutions throughout Latin Amer- 
ica and the Caribbean (Figure 3). This reporting, network, 
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Figure 3. Number of notification sites for acute flaccid paralysis. 
Americas, 1989-l 995. Source: SWPAHO. 
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Figure 4. Confirmed paralytic poliomyelitis cases and number of 
stool specimens tested from AFP cases and their contacts. Americas, 
1986-I 995. Source: SWPAHO. 
is now being utilized for the reporting of cases of 
measles, tetanus, and, in some countries cholera, and 
eventually will be expanded to include other communi- 
cable diseases. 
The last confirmed case of paralytic poliomyelitis due 
to wild polio virus had onset of paralysis on August 23, 
1991, in the town of Pichinaki, Department of Junin, 
Peru. By May 1996, over 4 years had elapsed since this 
historic event. Over this period, nearly 50,000 stool spec- 
imens from throughout the Americas have been tested 
without detection of wild polio virus (Figure 4). 
Surveillance Indicators 
The International Certification Commission on Polio Erad- 
ication (ICCPE) established by PAHO in 1990 has defined 
four basic components that are critical for the purposes 
of certification’: (1) surveillance of AFP (2) surveillance 
of wild polio virus, (3) active searches for AFP cases, and 
(4) mop-up vaccination campaigns in high risk areas. 
Countries were considered for certification only if they 
had been free of poliomyelitis for a period of at least 3 
years in the presence of adequate surveillance. 
For the surveillance of AFP the ICCPE established 
that the following five indicators must be met: 
At least 80% of all the health units included in the 
reporting network should be regularly reporting each 
week the absence or presence of AFI? 
The expected rate of AFP should be at least 1 .O cases 
per 100,000 children less than 15 years of age in any 
country. 
At least 80% of all AFP cases reported should be 
investigated within 48 hours of reporting. 
At least 80% of all AFP cases reported should have 
two stool specimens taken for virus culture within 
2 weeks of the onset of paralysis. 
5. At least 80% of all AFP cases reported should have 
stool investigations of at least five contacts. 
These indicators for 1994 for the Region of the Americas 
(the year of certification of eradication) are presented in 
Table 1. 
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Table 1. Surveillance Indicators Meeting Certification Criteria. 
Latin America, 1994 
80% 80% of Cases 80% of Cases 
Weekly Investigated with One 
Reporting within Adequate Stool AFP 
Country Units 48 Hours Sample Taken Rate 
Bolivia 
Chile 
Colombia - - - - 
Cuba - 
Dominican Republic - - 
Ecuador - - 
El Salvador - - 
Honduras - - 
Nicaragua - - - 
Venezuela - 
Argentina - 
Brazil - - 
Guatemala - 
Mexico - 
Panama - 
Paraguay - - 
Peru - 
Costa Rica - - 
Uruguay - 
Haiti 
- = Meet criteria. 
Source: SWPAHO (PESS). 
NATIONAL PLANNING AND INTER-AGENCY 
COORDINATION 
When PAHO, the Inter-American Development Bank 
(IDB), Rotary International, United Nations Children’s 
Fund (UNICEF), and United States Agency for Inter- 
national Development (USAID) joined forces in 1985 as 
the Inter-Agency Coordinating Committee (ICC) to launch 
the campaign to eradicate poliomyelitis in the Americas, 
they did so on the basis of a Regional Plan of Action. 
That Plan called for the creation of an ICC in each coun- 
try, which would in turn develop a national 5-year plan 
of action to program its EPI activities and plan its resource 
requirements. The first National Plans of Action (NPA) 
were developed by the newly created national ICCs 
(which subsequently also included the Canadian Public 
Health Association [CPHA]) for the 5-year period, 
1987- 1991. They serve as the basic instrument through 
which the host government, the ICC, and other organi- 
zations, including nongovernmental organizations (NGOs) 
that support EPI, coordinate their activities. They simul- 
taneously permit national EPI managers to plan and bud- 
get their use of resources in detail, including cost analyses 
of activities by type (capital/recurrent) and source 
(national/external). 
The NPAs, furthermore, make it possible to assess 
the sustainability of national immunization programs 
within the larger health service infrastructures. The like- 
lihood of financial sustainability to ensure that adequate 
personnel and supplies are available over time can be 
measured by the analysis of the NPA data. Comparing 
the budgets of the first and second 5-year work plans 
allows the ratio of national and external resources to be 
compared. In the first 5-year plan (1987-1991), 80% of 
the total cost of US $544.8 million was covered by 
national sources and 20% by external sources. For the 
second 5-year plan (1992-1996) a total of $774.9 million 
has been projected, of which nearly 90% will be pro- 
vided by national sources and 10% sought from external 
sources. The projected budget of $774.9 million repre- 
sents a 42% increase over the first 5-year plan and shows 
a significant increase in the level of national commitment 
to their programs. This indicates growth in sustainability, 
since the bulk of the vaccine costs are now covered by 
the national budgets. Simultaneously, the proportion 
being requested from external sources decreased to US 
$61.0 million for 1992-1996, compared with US $113.8 
million for 1987-1991.8 
PROGRESS TOWARD GLOBAL ERADICATION 
The 1988, World Health Assembly approved a resolution 
calling for the global eradication of poliomyelitis by the 
year 2000. Strategies now used in the global program fol- 
low those that proved successful in the Americas. They 
are (1) routine immunization with OPV; (2) national 
immunization days held twice a year in the endemic 
countries; (3) mop-up operations in the areas at risk; and 
(4) AFP and polio virus surveillance. 
However, it took 3 years for the global initiative to 
gain momentum. This momentum was initiated in the 
Western Pacific Region when that group of countries 
accelerated efforts toward eradication, with a major 
breakthrough when China launched a series of biannual 
NIDs, starting in 1993.9 It now appears that over 1 year 
has elapsed since the last isolation of wild polio virus in 
China. 
Global immunization coverage in children by 1 year 
of age has reached over 80%, and over 62 countries have 
now implemented or planned NIDs. For 1996,88 coun- 
tries have conducted or have planned to conduct NIDs 
(Figure 5). This is the first indicator of commitment 
toward polio eradication. India is the country that has 
contributed the majority of polio cases over the last few 
years. However, in December 1995 and January 1996, 
India implemented NIDs, with the vaccination of over 
90 million children under 5 years of age with the oral 
poliomyelitis vaccine. lo Sixteen African countries have 
planned NIDs for 1996, and this may be the beginning 
of the end of poliomyelitis in the world. 
Surveillance is now being implemented in the major- 
ity of countries, and a global polio laboratory network is 
now operational in most regions. The number of coun- 
tries reporting zero cases is increasing yearly (see Figure 
6), and the number of cases has declined from over 
35,000 in 1988 to about 6000 in 1995 (Figure 7).l’ 
A great threat to the global eradication of poliomye- 
litis will be the complacency that usually occurs when a 
disease becomes rare. Importations into regions that have 
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Figure 5. Number of countries worldwide conducting NIDs, 
1988-l 996. Data as of April 1996. Source: EPVWHO. 
already interrupted transmission from still endemic 
regions are also possibilities that may set back the pro- 
gram. Therefore, it is essential that all organizations 
(multilateral, bilateral, nongovernmental) that have aided 
the program thus far continue, now more than ever, to 
support the governments in their efforts to consolidate 
the eradication of polio. This will be critical to reinforce 
the national health infrastructure and the national immu- 
nization programs in their efforts to sustain -what has 
been achieved so far. The endemic countries themselves 
are contributing 80% of the total cost of eradication. How- 
ever, it is estimated that US $500 million of external sup- 
port will be needed over the next 5 years for the 
achievement of the objective, and 80% of this required 
assistance is for the purchase of oral polio vaccine. 
The eradication of poliomyelitis from th[e world, 
which is now within grasp, together with the global erad- 
ication of smallpox, is a confirmation of the power of 
vaccines in improving human health. Therefore, the great- 
est challenge currently is to ensure that the political and 
social will, demonstrated so far, will be maintained in the 
years to come. Failure to do so will jeopardize the global 
eradication of polio and will impede the attainment of 
other established health goals. The success of the polio 
eradication initiative has led countries to accelerate their 
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Figure 6. Number of countries reporting zero polio cases, 1988-l 995. 
Data as of April 1996. Source: EPVWHO. 
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Figure 7. Global annual reported polio cases, 1988-1995. Data as 
of April 1996. Source: EPIiWHO. 
efforts to control or eradicate measles and to eliminate 
neonatal tetanus, targets set forth in 1990 by the Summit 
for the World’s Children. These initiatives must be given 
a high priority to maintain the momentum that is needed. 
These initiatives must also be given the required 
resources, both human and financial, to be successful. It 
remains to be seen if society will keep its commitment 
to the health of future generations. 
REFERENCES 
1. de Quadros CA, Andrus JK, Olive JM, de Macedo CG, Hen- 
derson DA. Polio eradication from the western hemisphere. 
Annu Rev Pub Health 1992; 13:239-252. 
2. de Quadros CA. More effective immunization. Proc R Sot 
Lond [Biol] 1980; 209: 11 I- 118. 
3. Risi JB Jr. The control of poliomyelitis in Brazil. Rev Infect 
Dis 1984; G(Suppl2):S400-S403. 
4. Sabin AB. Strategies for the elimination of poliomyelitis in 
different parts of the world using OPV Rev Infect Dis 1984; 
G(supp1 2):S391-S396. 
5. Rodriguez Cruz R. Cuba: mass vaccination against polio- 
myelitis. Rev Infect Dis 1984; G(Supp1 2):S408-S412. 
6. Pan American Health Organization. EPI Newsletter. 1992; 
xIv(5):l. 
7. Pan American Health Organization. Plan of action for the 
certification of eradication of wild polio virus from the 
Americas. PAHO Technical Paper No. 39, March 1993. 
8. Pan American Health Organization. Expanded program on 
immunization. Progress report by the Director. 118th Meet- 
ing of the PAHO Executive Committee. PAHO Document 
CEllS/lS. Washington, DC: PAHO, April 1996. 
9. World Health Organization. Progress towards the global 
eradication of poliomyelitis. Status of polio eradication in the 
Western Pacific Region. WHO Document EPI/POLIO/ 
PROG.96/Wl?l9. Geneva, Switzerland: WHO, May 1996. 
10. World Health Organization. Progress towards the global 
eradication of poliomyelitis. Status of polio eradication in the 
South-East Asia Region. WHO Document EPI/POLIO/ 
PROG.96/WP24. Geneva, Switzerland: WHO, May 1996. 
11. World Health Organization. Progress towards the global 
eradication of poliomyelitis. Global overview. WHO Docu- 
ment EPI/POLIO/PROG.96/WPOl. Geneva, Switzerland: 
WHO, May 1996. 
